More on VNDA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-126.1% Growth)
- Ratings (7.3 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (10/29/26 *Est.)
- M&A (Rumor)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Vanda Pharmaceuticals (NQ:VNDA)
Delayed: 5.28 -0.1 (1.86%)
Prev. Close $5.38  
Open$5.42 
52 Wk High$18.00 
52 Wk Low$6.91 
Day High$5.42 
Day Low$5.27 
P/E N/A  
EPS$-0.67 
Volume656,794 

Friends, Peers and Foes (?): ANAB, ACAD, ALKS, AXSM, CPRX (more...)

Aug 19, 2026 06:32 PM Form SCHEDULE 13G Vanda Pharmaceuticals Filed by: MILLENNIUM MANAGEMENT LLC
Aug 15, 2026 10:00 AM This biotech stock offers a buying opportunity: B. Riley
Aug 13, 2026 09:23 AM Form SCHEDULE 13G Vanda Pharmaceuticals Filed by: AQR CAPITAL MANAGEMENT LLC
Aug 10, 2026 08:18 AM Vanda Pharmaceuticals (VNDA) PT Lowered to $12 at B.Riley
Aug 10, 2026 06:49 AM Vanda Pharmaceuticals (VNDA) PT Lowered to $20 at H.C. Wainwright
Aug 6, 2026 07:39 AM Form 10-Q Vanda Pharmaceuticals For: Jun 30
Aug 5, 2026 04:05 PM Vanda Pharmaceuticals (VNDA) Misses Q2 EPS by 44c; Offers Guidance
Aug 5, 2026 04:05 PM Form 8-K Vanda Pharmaceuticals For: Aug 05
Aug 5, 2026 04:01 PM Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results
Jul 29, 2026 04:32 PM Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026
View All Articles

Entities mentioned with VNDA

View All Entities